Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Virostatics s.r.l.
DescriptionEnterically-coated fixed-dose combination of dideoxyinosine and hydroxycarbamide
Molecular Target Ribonucleotide reductase
Mechanism of ActionImmune modulation
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today